Efficacy of Initiation of Semaglutide versus SGLT2 Inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Propensity-Matched Real-World Study

Endocrine Practice · Published 2026-06-01 · DOI 10.1016/j.eprac.2026.06.004

Authors (12)

Ibrahim Khalil, Pallab Sarker, Md. Imran Hossain, Anika Chowdhury, Aizaz Anwar Khalid, Ananna Saha, Joydip Chowdhury, Mst. Mahmuda Akter, Sunjida Amin Promi, Md Abu Sayed, Mohd Turzo Rahman, A.B.M. Kamrul-Hasan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Khalil, I., Sarker, P., Hossain, M., et al. (2026). Efficacy of Initiation of Semaglutide versus SGLT2 Inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Propensity-Matched Real-World Study. Endocrine Practice. https://doi.org/10.1016/j.eprac.2026.06.004

Related articles